Supercritical fluid technology offers opportunities for pharmaceutical manufacturing but faces challenges for widespread adoption. It can be used for particle size reduction, drug delivery system design, and extraction. However, challenges include developing feasible scale-up designs, accurately modeling solute behavior, high capital costs of equipment, and difficulties producing products consistently at an industrial scale. Overcoming these challenges through continued research, development, and validation of continuous production processes could realize the full potential of this technology.